Kunming Longjin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Kunming Longjin Pharmaceutical has a total shareholder equity of CN¥528.6M and total debt of CN¥1.0M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥597.4M and CN¥68.8M respectively.
Key information
0.2%
Debt to equity ratio
CN¥1.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥303.19m |
| Equity | CN¥528.62m |
| Total liabilities | CN¥68.75m |
| Total assets | CN¥597.37m |
Recent financial health updates
Recent updates
What Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) 38% Share Price Gain Is Not Telling You
Aug 14
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet
Jun 30Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08Financial Position Analysis
Short Term Liabilities: 002750's short term assets (CN¥354.6M) exceed its short term liabilities (CN¥42.0M).
Long Term Liabilities: 002750's short term assets (CN¥354.6M) exceed its long term liabilities (CN¥26.7M).
Debt to Equity History and Analysis
Debt Level: 002750 has more cash than its total debt.
Reducing Debt: 002750's debt to equity ratio has increased from 0% to 0.2% over the past 5 years.
Debt Coverage: 002750's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002750's interest payments on its debt are well covered by EBIT.